Literature DB >> 2483349

5-Aza-2'-deoxycytidine as a differentiation inducer in acute myeloid leukaemias and myelodysplastic syndromes of the elderly.

A Pinto1, V Zagonel, V Attadia, P L Bullian, V Gattei, A Carbone, S Monfardini, A Colombatti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2483349

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

Review 1.  New therapeutic targets in cancer: the epigenetic connection.

Authors:  Michel Herranz; Manel Esteller
Journal:  Clin Transl Oncol       Date:  2006-04       Impact factor: 3.405

Review 2.  Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries.

Authors:  Patompon Wongtrakoongate
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

Review 3.  Clinical development of demethylating agents in hematology.

Authors:  Shyamala C Navada; Juliane Steinmann; Michael Lübbert; Lewis R Silverman
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

4.  Genomic impact of transient low-dose decitabine treatment on primary AML cells.

Authors:  Jeffery M Klco; David H Spencer; Tamara L Lamprecht; Shawn M Sarkaria; Todd Wylie; Vincent Magrini; Jasreet Hundal; Jason Walker; Nobish Varghese; Petra Erdmann-Gilmore; Cheryl F Lichti; Matthew R Meyer; R Reid Townsend; Richard K Wilson; Elaine R Mardis; Timothy J Ley
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

5.  Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response.

Authors:  Bryan J Schneider; Manish A Shah; Kelsey Klute; Allyson Ocean; Elizabeta Popa; Nasser Altorki; Michael Lieberman; Andrew Schreiner; Rhonda Yantiss; Paul J Christos; Romae Palmer; Daoqi You; Agnes Viale; Pouneh Kermani; Joseph M Scandura
Journal:  Clin Cancer Res       Date:  2016-11-10       Impact factor: 12.531

Review 6.  DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

Authors:  Björn Rüter; Pierre W Wijermans; Michael Lübbert
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

7.  Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy.

Authors:  Metin Karahoca; Richard L Momparler
Journal:  Clin Epigenetics       Date:  2013-02-01       Impact factor: 6.551

8.  Decitabine in the treatment of myelodysplastic syndromes.

Authors:  Hussain I Saba
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

Review 9.  Epigenetics in cancer stem cells.

Authors:  Tan Boon Toh; Jhin Jieh Lim; Edward Kai-Hua Chow
Journal:  Mol Cancer       Date:  2017-02-01       Impact factor: 27.401

Review 10.  Epigenetic modifications of embryonic stem cells: current trends and relevance in developing regenerative medicine.

Authors:  Henry Chung; Kuldip S Sidhu
Journal:  Stem Cells Cloning       Date:  2008-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.